US Patent Issued to MEDIMMUNE on Jan. 28 for "Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer" (British Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,099, issued on Jan. 28, was assigned to MEDIMMUNE Ltd. (Cambridge, Great Britain).

"Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer" was invented by Philip Wilson Howard (Cambridge, Great Britain) and Thais Cailleau (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound of formula IV: as well as drug-linkers and conjugates comprising this compound, and the use of the conjugates in treating cancer."

The patent was filed on March 13, 2020, under Application No. 17/439,639.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/net...